- Natural-Product-Mediated Autophagy in the Treatment of Various Liver Diseases
Guifang Fan et al, 2022, International Journal of Molecular Sciences CrossRef - Feasibility and Safety of Food Containing Acanthopanax senticosus for Treating Patients with Cancer-Related Fatigue
Yutaka Kawano et al, 2024, Palliative Medicine Reports CrossRef - A Gedunin-Type Limonoid, 7-Deacetoxy-7-Oxogedunin, from Andiroba (Carapa guianensis Aublet) Reduced Intracellular Triglyceride Content and Enhanced Autophagy in HepG2 Cells
Akifumi Nagatomo et al, 2022, International Journal of Molecular Sciences CrossRef - Acanthopanax senticosus ameliorates steatohepatitis through HNF4 alpha pathway activation in mice
Yutaka Kawano et al, 2024, Scientific Reports CrossRef - Exploring potential mechanism of ciwujia tablets for insomnia by UPLC-Q-TOF-MS/MS, network pharmacology, and experimental validation
Hongda Liu et al, 2022, Frontiers in Pharmacology CrossRef - Phytochemical composition and bioactive effects of ethyl acetate fraction extract (EAFE) of Glechoma hederacea L.
Wen Wan Chao et al, 2021, Journal of Food Biochemistry CrossRef - Eleutheroside E from pre-treatment of Acanthopanax senticosus (Rupr.etMaxim.) Harms ameliorates high-altitude-induced heart injury by regulating NLRP3 inflammasome-mediated pyroptosis via NLRP3/caspase-1 pathway
Nan Jia et al, 2023, International Immunopharmacology CrossRef - KIF4 enforces the progression of colorectal cancer by inhibiting the autophagy via activating the Hedgehog signaling pathway
Yuxiang Fu et al, 2022, Archives of Biochemistry and Biophysics CrossRef - Rubicon can predict prognosis in patients with pancreatic ductal adenocarcinoma after neoadjuvant chemoradiotherapy
Daiki Marukawa et al, 2023, International Journal of Clinical Oncology CrossRef - Eleutheroside E functions as anti-cervical cancer drug by inhibiting the phosphatidylinositol 3-kinase pathway and reprogramming the metabolic responses
Yipin Cai et al, 2022, Journal of Pharmacy and Pharmacology CrossRef - Nitidine chloride inhibits G2/M phase by regulating the p53/14-3-3 Sigma/CDK1 axis for hepatocellular carcinoma treatment
Bo Zhang et al, 2024, Heliyon CrossRef